# OnCo record skin-cancer-after-organ-transplant (term). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/terms/skin-cancer-after-organ-transplant/>
  a schema:DefinedTerm ;
  onco:kind "term" ;
  schema:identifier "skin-cancer-after-organ-transplant" ;
  schema:name "Skin cancer after an organ transplant"@en ;
  schema:alternateName "skin cancer in transplant recipients"@en, "immunosuppressed skin cancer"@en, "solid organ transplant recipient skin cancer"@en, "post-transplant squamous cell carcinoma"@en ;
  schema:description "The drugs that keep a transplanted organ alive let skin cancers grow, and they grow differently: faster, in numbers, and far more likely to spread. This group is large, it is getting larger as transplant recipients live longer, and almost every trial of the drugs that would help them has excluded them."@en ;
  schema:url <https://onco.cc/terms/skin-cancer-after-organ-transplant/> ;
  schema:dateModified "2026-09-25"^^xsd:date ;
  schema:citation <https://doi.org/10.1056/NEJMoa1204166>, <https://doi.org/10.1200/JCO.23.01498>, <https://doi.org/10.1001/jamadermatol.2025.3238>, <https://www.skinhealthinfo.org.uk/condition/skin-cancer-in-organ-transplant-recipients/>, <https://doi.org/10.1002/ijc.27765>, <https://doi.org/10.1001/jamadermatol.2016.4920>, <https://doi.org/10.1016/S1470-2045(08)70178-5> ;
  onco:related <https://onco.cc/terms/second-primary-skin-cancer/>, <https://onco.cc/terms/sun-protection-after-skin-cancer/>, <https://onco.cc/technologies/chemoprevention/>, <https://onco.cc/pathways/field-cancerisation/> ;
  onco:cancers <https://onco.cc/cancers/cutaneous-scc/>, <https://onco.cc/cancers/skin-cancer/>, <https://onco.cc/cancers/advanced-cutaneous-scc/>, <https://onco.cc/cancers/basal-cell-carcinoma/> ;
  onco:sections <https://onco.cc/fronts/prevention/>, <https://onco.cc/fronts/early-detection/> ;
  onco:technologies <https://onco.cc/technologies/chemoprevention/>, <https://onco.cc/technologies/checkpoint-inhibitor/> ;
  onco:drugs <https://onco.cc/drugs/cemiplimab/>, <https://onco.cc/drugs/acitretin/>, <https://onco.cc/drugs/nicotinamide/>, <https://onco.cc/drugs/sirolimus/> ;
  onco:terms <https://onco.cc/pathways/field-cancerisation/>, <https://onco.cc/terms/irae/> ;
  onco:trials <https://onco.cc/trials/tumorapa/>, <https://onco.cc/trials/cemiplimab-kidney-transplant-cscc/>, <https://onco.cc/trials/empower-cscc-1/> .